Slide
NovochizolTM

First-in-class polysaccharide nanospheres.

Slide
NovochizolTM

Targeted delivery of any active ingredient
at site of administration.

Slide
NovochizolTM

Intracellular delivery of macromolecules
in different cell types.

Slide
NovochizolTM

Sustained, localized release without
systemic effects

Slide
NovochizolTM

Aerosol formulations for mucosal
and intra-pulmonary delivery.

previous arrow
next arrow

Press Release

Novochizol has been selected by Boehringer Ingelheim as one of the winners of the opnMe novel drug delivery solutions contest.

Bioark, Monthey, September 15, 2021: Novochizol SA, a biotech company with a unique chitosan-based drug formulation nanotechnology, today announced that it has been selected as one of the winners of the opnMe “innovative drug delivery solutions” contest.

What is NovochizolTM?

Novochizol™ technology quantitatively transforms single linear chitosan molecules into cross-linked, uniformly sized nanospheres. They can be used alone for their anti-inflammatory and immune-stimulating properties or as bioadherent carriers. Any type of biologically active substance can be formulated: small molecules, peptides, nucleic acids, and proteins. Novochizol™ retains all the benefits of chitosan and overcomes all of its limitations, offering first-in-class solutions in therapeutics, diagnostics, tissue engineering, and material sciences.

Why use NovochizolTM?

  • Strong adherence to tissues or materials at site of application.
  • Injectable, oral, or topical formulations, aerosols, solid matrices.
  • Sustained local release of any API, without systemic distribution.
  • Intracellular delivery of even large proteins targeting a variety of cell types.
  • Formulation of even the most recalcitrant active ingredients.
  • Safety profile inherited from chitosan (GRAS).
  • Numerous applications in pharma, medical devices, agriculture and cosmetics.

For more Information

News

"Impossible n'est pas français" (Napoléon)

History proved Napoleon not exactly right... But what if "Formulation impossible n'est pas Novochizol" were true?
Challenge us ! (you may even win a box of Swiss chocolates...) Read more

First paper describing use of NovochizolTM published

In the very first academic publication that describes NovochizolTM research*, Anna Lipkova et al. studied the mechanical properties of bacterial cellulose impregnated with NovochizolTM Read more

Novochizol at Nanobiotech-Montreux 2021

Novochizol has been selected by the Conference organizing committee to present its technology and selected applications at the next edition of the conference Read More

Subscribe to our Newsletter

NovochizolTM R&D is moving fast !